DLA
CL icon

Douglas Lane & Associates’s Colgate-Palmolive CL Stock Holding History

Douglas Lane & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
17,968
+31
+0.2% +$2.71K 0.02% 153
2026
Q1 		$1.53M Sell
17,937
-22
-0.1% -$1.96K 0.02% 146
2025
Q4 		$1.42M Buy
17,959
+5
+0% +$392 0.02% 147
2025
Q3 		$1.44M Sell
17,954
-1,020
-5% -$87K 0.02% 149
2025
Q2 		$1.72M Sell
18,974
-1,041
-5% -$95K 0.03% 144
2025
Q1 		$1.88M Sell
20,015
-267
-1% -$23.9K 0.03% 145
2024
Q4 		$1.84M Sell
20,282
-52
-0.3% -$4.96K 0.03% 146
2024
Q3 		$2.11M Sell
20,334
-975
-5% -$99.4K 0.03% 143
2024
Q2 		$2.07M Sell
21,309
-527
-2% -$48.6K 0.03% 141
2024
Q1 		$1.97M Buy
21,836
+152
+0.7% +$12.9K 0.03% 143
2023
Q4 		$1.73M Sell
21,684
-1,325
-6% -$99.6K 0.03% 144
2023
Q3 		$1.64M Hold
23,009
– – 0.03% 135
2023
Q2 		$1.77M Hold
23,009
– – 0.03% 134
2023
Q1 		$1.73M Sell
23,009
-700
-3% -$52.1K 0.03% 138
2022
Q4 		$1.87M Sell
23,709
-183
-0.8% -$13.7K 0.03% 136
2022
Q3 		$1.68M Hold
23,892
– – 0.03% 135
2022
Q2 		$1.92M Sell
23,892
-550
-2% -$43K 0.03% 135
2022
Q1 		$1.85M Sell
24,442
-1,875
-7% -$149K 0.03% 141
2021
Q4 		$2.25M Sell
26,317
-1,062
-4% -$82.9K 0.03% 140
2021
Q3 		$2.07M Sell
27,379
-798
-3% -$63.4K 0.03% 136
2021
Q2 		$2.29M Sell
28,177
-1,366
-5% -$112K 0.03% 133
2021
Q1 		$2.33M Buy
29,543
+5,780
+24% +$453K 0.04% 127
2020
Q4 		$2.03M Sell
23,763
-354
-1% -$29.3K 0.03% 127
2020
Q3 		$1.86M Sell
24,117
-518
-2% -$39.5K 0.04% 126
2020
Q2 		$1.8M Sell
24,635
-813
-3% -$57.8K 0.04% 122
2020
Q1 		$1.69M Sell
25,448
-993
-4% -$70K 0.04% 124
2019
Q4 		$1.82M Sell
26,441
-2,110
-7% -$144K 0.03% 129
2019
Q3 		$2.1M Sell
28,551
-1,647
-5% -$119K 0.04% 126
2019
Q2 		$2.16M Sell
30,198
-5,678
-16% -$403K 0.04% 129
2019
Q1 		$2.46M Sell
35,876
-595
-2% -$38.4K 0.05% 124
2018
Q4 		$2.17M Sell
36,471
-5,854
-14% -$366K 0.05% 123
2018
Q3 		$2.83M Sell
42,325
-5,673
-12% -$378K 0.06% 122
2018
Q2 		$3.11M Sell
47,998
-4,433
-8% -$290K 0.07% 115
2018
Q1 		$3.76M Sell
52,431
-3,410
-6% -$245K 0.08% 110
2017
Q4 		$4.21M Sell
55,841
-6,229
-10% -$455K 0.09% 110
2017
Q3 		$4.52M Sell
62,070
-37,069
-37% -$2.67M 0.1% 109
2017
Q2 		$7.35M Sell
99,139
-23,821
-19% -$1.77M 0.17% 101
2017
Q1 		$9M Sell
122,960
-24,883
-17% -$1.74M 0.22% 102
2016
Q4 		$9.68M Sell
147,843
-29,781
-17% -$2.04M 0.25% 96
2016
Q3 		$13.2M Sell
177,624
-3,309
-2% -$245K 0.35% 85
2016
Q2 		$13.2M Sell
180,933
-3,190
-2% -$227K 0.38% 87
2016
Q1 		$13M Buy
+184,123
New +$12.2M 0.36% 94

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Douglas Lane & Associates's CL Position: Q2 2026 in Review

Douglas Lane & Associates increased its Colgate-Palmolive (CL) stake by 0.17% in Q2 2026, buying an estimated $2.71K and bringing the position to 17,968 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #153.

Douglas Lane & Associates first reported a position in CL in Q1 2016 and has held it in 42 quarters since. The position peaked at $13.2M in Q2 2016. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Douglas Lane & Associates held 17,968 shares of Colgate-Palmolive worth $1.65M as of Q2 2026.
  • Douglas Lane & Associates bought 31 Colgate-Palmolive shares in Q2 2026, an estimated $2.71K.
  • Colgate-Palmolive made up 0.02% of Douglas Lane & Associates's portfolio in Q2 2026, its #153 holding.
  • Douglas Lane & Associates first reported a position in Colgate-Palmolive in Q1 2016 and has held it in 42 quarters since.
  • Douglas Lane & Associates's Colgate-Palmolive position peaked at $13.2M in Q2 2016.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.